Abstract Introduction Since October 2012, the combined tetanus toxoid, reduced diphtheria
toxoid, acellular pertussis vaccine (Tdap) has been recommended in the United States …

Infants are at risk for pertussis-related morbidity and mortality especially in the early months
of life when they are too young to be vaccinated. Beginning in 2012, tetanus toxoid, reduced …

Objective In response to widespread pertussis outbreaks and infant deaths, in 2010, the
California Department of Health (CDPH) and in 2011 the Advisory Committee on …

Importance The Advisory Committee on Immunization Practices (ACIP) recommends the
tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each …

Importance In 2010, due to a pertussis outbreak and neonatal deaths, the California
Department of Health recommended that the tetanus toxoid, reduced diphtheria toxoid, and …

OBJECTIVE: To evaluate the safety of coadministering tetanus toxoid, reduced diphtheria
toxoid, and acellular pertussis (Tdap) and influenza vaccines during pregnancy by …

Abstract Background In October 2011, the Advisory Committee on Immunization Practices
(ACIP) issued updated recommendations that all pregnant women routinely receive a dose …

Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …

Introduction At present, pregnant women in the US are recommended to receive tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) and influenza vaccines …

OBJECTIVE: To evaluate how implementation of a best-practice alert, a reminder of clinical
guidelines within the electronic medical record, in combination with the recommended …